These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37305410)

  • 1. Comparative evaluation of protective immunity against
    Zhao M; Zhai Y; Zai X; Mao Y; Hu E; Wei Z; Li Y; Li K; Liu Y; Xu J; Yu R; Chen W
    Front Cell Infect Microbiol; 2023; 13():1195314. PubMed ID: 37305410
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective immunity against tularemia provided by an adenovirus-vectored vaccine expressing Tul4 of Francisella tularensis.
    Kaur R; Chen S; Arévalo MT; Xu Q; Chen Y; Zeng M
    Clin Vaccine Immunol; 2012 Mar; 19(3):359-64. PubMed ID: 22278325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mucosal subunit vaccine protects against lethal respiratory infection with Francisella tularensis LVS.
    Ashtekar AR; Katz J; Xu Q; Michalek SM
    PLoS One; 2012; 7(11):e50460. PubMed ID: 23209745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of Francisella tularensis outer membrane protein A (FopA) as a protective antigen for tularemia.
    Hickey AJ; Hazlett KR; Kirimanjeswara GS; Metzger DW
    Vaccine; 2011 Sep; 29(40):6941-7. PubMed ID: 21803089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intranasal administration of a two-dose adjuvanted multi-antigen TMV-subunit conjugate vaccine fully protects mice against Francisella tularensis LVS challenge.
    McCormick AA; Shakeel A; Yi C; Kaur H; Mansour AM; Bakshi CS
    PLoS One; 2018; 13(4):e0194614. PubMed ID: 29684046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Synthetic Tul4 and FopA Peptide Cocktail of Francisella tularensis Induces Humoral and Cell-Mediated Immune Responses in Mice.
    Oh H; Kim CY; Kim CH; Hur GH; Park JH
    J Microbiol Biotechnol; 2016 Sep; 26(9):1613-9. PubMed ID: 27238938
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic modification of the O-polysaccharide of Francisella tularensis results in an avirulent live attenuated vaccine.
    Kim TH; Pinkham JT; Heninger SJ; Chalabaev S; Kasper DL
    J Infect Dis; 2012 Apr; 205(7):1056-65. PubMed ID: 21969334
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An improved vaccine for prevention of respiratory tularemia caused by Francisella tularensis SchuS4 strain.
    Bakshi CS; Malik M; Mahawar M; Kirimanjeswara GS; Hazlett KR; Palmer LE; Furie MB; Singh R; Melendez JA; Sellati TJ; Metzger DW
    Vaccine; 2008 Sep; 26(41):5276-88. PubMed ID: 18692537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Improved Tobacco Mosaic Virus (TMV)-Conjugated Multiantigen Subunit Vaccine Against Respiratory Tularemia.
    Mansour AA; Banik S; Suresh RV; Kaur H; Malik M; McCormick AA; Bakshi CS
    Front Microbiol; 2018; 9():1195. PubMed ID: 29922267
    [No Abstract]   [Full Text] [Related]  

  • 10. A Francisella tularensis live vaccine strain (LVS) mutant with a deletion in capB, encoding a putative capsular biosynthesis protein, is significantly more attenuated than LVS yet induces potent protective immunity in mice against F. tularensis challenge.
    Jia Q; Lee BY; Bowen R; Dillon BJ; Som SM; Horwitz MA
    Infect Immun; 2010 Oct; 78(10):4341-55. PubMed ID: 20643859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Francisella tularensis Live Vaccine Strain deficient in capB and overexpressing the fusion protein of IglA, IglB, and IglC from the bfr promoter induces improved protection against F. tularensis respiratory challenge.
    Jia Q; Bowen R; Lee BY; Dillon BJ; Masleša-Galić S; Horwitz MA
    Vaccine; 2016 Sep; 34(41):4969-4978. PubMed ID: 27577555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel catanionic surfactant vesicle vaccines protect against Francisella tularensis LVS and confer significant partial protection against F. tularensis Schu S4 strain.
    Richard K; Mann BJ; Stocker L; Barry EM; Qin A; Cole LE; Hurley MT; Ernst RK; Michalek SM; Stein DC; Deshong P; Vogel SN
    Clin Vaccine Immunol; 2014 Feb; 21(2):212-26. PubMed ID: 24351755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Multivalent Subunit Vaccine against Tularemia Using Tobacco Mosaic Virus (TMV) Based Delivery System.
    Banik S; Mansour AA; Suresh RV; Wykoff-Clary S; Malik M; McCormick AA; Bakshi CS
    PLoS One; 2015; 10(6):e0130858. PubMed ID: 26098553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 15. A heterologous prime-boost vaccination strategy comprising the Francisella tularensis live vaccine strain capB mutant and recombinant attenuated Listeria monocytogenes expressing F. tularensis IglC induces potent protective immunity in mice against virulent F. tularensis aerosol challenge.
    Jia Q; Bowen R; Sahakian J; Dillon BJ; Horwitz MA
    Infect Immun; 2013 May; 81(5):1550-61. PubMed ID: 23439306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral immunization of mice with the live vaccine strain (LVS) of Francisella tularensis protects mice against respiratory challenge with virulent type A F. tularensis.
    KuoLee R; Harris G; Conlan JW; Chen W
    Vaccine; 2007 May; 25(19):3781-91. PubMed ID: 17346863
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral live vaccine strain-induced protective immunity against pulmonary Francisella tularensis challenge is mediated by CD4+ T cells and antibodies, including immunoglobulin A.
    Ray HJ; Cong Y; Murthy AK; Selby DM; Klose KE; Barker JR; Guentzel MN; Arulanandam BP
    Clin Vaccine Immunol; 2009 Apr; 16(4):444-52. PubMed ID: 19211773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Humoral and cell-mediated immunity in mice to a 17-kilodalton lipoprotein of Francisella tularensis expressed by Salmonella typhimurium.
    Sjöstedt A; Sandström G; Tärnvik A
    Infect Immun; 1992 Jul; 60(7):2855-62. PubMed ID: 1612751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inactivated Francisella tularensis live vaccine strain protects against respiratory tularemia by intranasal vaccination in an immunoglobulin A-dependent fashion.
    Baron SD; Singh R; Metzger DW
    Infect Immun; 2007 May; 75(5):2152-62. PubMed ID: 17296747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical testing of a vaccine candidate against tularemia.
    Suresh RV; Ma Z; Sunagar R; Bhatty V; Banik S; Catlett SV; Gosselin EJ; Malik M; Bakshi CS
    PLoS One; 2015; 10(4):e0124326. PubMed ID: 25897786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.